Phathom Pharmaceuticals (PHAT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist

15.720
+1.780+12.77%

Close Aug 27 16:00 ET

1.07BMarket Cap-3034P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Phathom Pharmaceuticals' V Oquezna: A Rising Star in GERD Treatment Market
TipRanksAug 23 12:25 ET
Express News | Phathom Pharmaceuticals Prices Offering Of 8.7M Shares And 2.6M Pre-Funded Warrants At $11.50 Per Share, Raising Approximately $130M
BenzingaAug 19 08:02 ET
Express News | Phathom Pharmaceuticals Inc - Prices Underwritten Offering at $11.50 per Share
ReutersAug 19 08:00 ET
Express News | Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
ReutersAug 19 08:00 ET
Needham Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $26
Moomoo NewsAug 16 10:31 ET · Ratings
Buy Rating Justified by Phathom Pharmaceuticals' V Oquezna Market Expansion and Positive Prescription Trends
TipRanksAug 16 10:05 ET · Ratings

Comments

Xyno

Aug 15 09:36

$Phathom Pharmaceuticals (PHAT.US)$ breaking free of the shackles..! up she goes

TokiShadow

Aug 6 08:58

PHAT Shorts

$Phathom Pharmaceuticals (PHAT.US)$ would be nice if the shorts would just give it up already. oh well, longer time to build a bag.

Xyno

Jul 31 07:10

$Phathom Pharmaceuticals (PHAT.US)$ Lots of nervous trading going on. Once the shake out of shorters has been completed in a few weeks time and with the earnings on 8/8 this baby will go north

Iceviper

Jul 19 08:39

$Phathom Pharmaceuticals (PHAT.US)$ In a report released today, from Needham maintained a Buy rating on Phathom Pharmaceuticals ( – ), with a price target of $26.00.
Joseph Stringer has given his Buy rating due to a combination of factors surrounding the recent developments at Phathom Pharmaceuticals. Stringer’s optimism is anchored in the approval of Voquezna for Non-Erosive GERD (NERD), a market considerably larger than the drug’s previous indications. This label expansion is expected to have ...

Meltyy

Jul 18 22:03

$Phathom Pharmaceuticals (PHAT.US)$ FDA Approves VOQUEZNA® for Relief of Heartburn
Associated w/ Non-Erosive GERD in Adults
» now approved for Non-Erosive GERD ✨
» demonstrated rapid heartburn relief in Ph3 trials
» represents the 1st major GERD innovation in 30 years
» the only FDA-approved Tx of its kind available 👏

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

PHAT Phathom Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target